Cancer Drugs Approved Based on Biomarkers and Not Tumor Type

This Viewpoint examines the recent US Food and Drug Administration approval of pembrolizumab and its implications for precision oncology and tumor-type classifications.

from Cancer via ola Kala on Inoreader http://ift.tt/2DrFFvw
via IFTTT